Cancer colorectal : essais cliniques en Suisse
21 essais ouverts en Suisse pour le cancer colorectal et 16 essais ouverts à plusieurs types de cancer, d'après ClinicalTrials.gov, mis à jour le 20 octobre 2026.
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.
Essais ouverts
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
NCT06428409Recrutement en coursPhase 1 · Phase 2
En Suisse : Bellinzona, Genève
- A Beta-only IL-2 ImmunoTherapY Study
NCT05086692Recrutement en coursPhase 1 · Phase 2
En Suisse : Zurich
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849Recrutement en coursPhase 3
En Suisse : Berne, Lausanne, Saint-Gall
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Recrutement en coursPhase 1
En Suisse : Saint-Gall, Winterthour
- Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
NCT07829081Recrutement en cours
En Suisse : Bâle, Bienne, Lucerne
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Recrutement en coursPhase 1
En Suisse : Genève, Lausanne
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651Recrutement en coursPhase 3
En Suisse : Schlieren, Zurich
- Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
NCT07617610Recrutement en cours
En Suisse : Aarau, Baden, Bâle, Berne, Bienne, Coire, Lucerne, Saint-Gall, Solothurn, Villars-sur-Glâne, Winterthour, Zurich
- Efficacy and Safety of the CG-100 Intraluminal Bypass Device
NCT04184973Recrutement en cours
En Suisse : Lausanne
- A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
NCT06567782Recrutement en coursPhase 2
En Suisse : Berne, Genève
- Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
NCT06936774Recrutement en coursPhase 3
En Suisse : Bâle, Berne, Lucerne, Winterthour
- Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
NCT06249672Recrutement en cours
En Suisse : Berne
- The Development of MASLD Among Survivors of Breast or Colorectal Cancer
NCT07280143Recrutement en cours
En Suisse : Berne
- Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
NCT05748145Recrutement en coursPhase 2
En Suisse : Bellinzona
- Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Recrutement en cours
En Suisse : Genève
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT06462963Recrutement en cours
En Suisse : Berne, Zurich
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
NCT05502380Recrutement en coursPhase 3
En Suisse : Zurich
- The DRAGON 2 Trial
NCT05428735Recrutement en cours
En Suisse : Bâle, Winterthour
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT04498767Recrutement en cours
En Suisse : Berne, Zurich
- Long-term Cohort Study of Mesorectal Excision for Rectal Cancer
NCT05112016Recrutement en cours
En Suisse : Winterthour
- Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
NCT04109755Recrutement en coursPhase 2
En Suisse : Genève
Essais ouverts à plusieurs types de cancer
Ces essais acceptent plusieurs types de cancer, peut-être le vôtre : parlez-en à votre médecin.
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
NCT07785609Recrutement en coursPhase 2
En Suisse : Bellinzona, Saint-Gall
- A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)
NCT07793942Pas encore en recrutementPhase 2
En Suisse : Lausanne, Saint-Gall
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
NCT05067283Recrutement en coursPhase 1
En Suisse : Bellinzona, Saint-Gall
- Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908Recrutement en coursPhase 1
En Suisse : Zurich
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819Recrutement en coursPhase 2
En Suisse : Berne, Genève, Zurich
- Safety and Early Signs of Efficacy of IL12-L19L19.
NCT04471987Recrutement en coursPhase 1
En Suisse : Bâle, Bellinzona, Berne, Genève
- A Nutrition and Exercise Program With Olanzapine Compared to Olanzapine Alone: A Trial in Patients With Advanced Tumors
NCT07722806Pas encore en recrutementPhase 2
En Suisse : Winterthour
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
NCT05836324Recrutement en coursPhase 1
En Suisse : Bellinzona, Lausanne, Saint-Gall
- A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
NCT07172919Recrutement en coursPhase 2
En Suisse : Bâle
- A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT05384626Recrutement en coursPhase 1 · Phase 2
En Suisse : Bellinzona, Lucerne
- A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
NCT06725758Recrutement en coursPhase 1 · Phase 2
En Suisse : Bellinzona
- First in Human Study of T3P-Y058-739 (T3P)
NCT05120596Recrutement en coursPhase 1 · Phase 2
En Suisse : Berne, Lausanne, Zurich
- Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766Recrutement en cours
En Suisse : Bellinzona
- A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
NCT04775485Recrutement en coursPhase 2
En Suisse : Zurich
- Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
NCT06408688Recrutement en coursPhase 4
En Suisse : Baden, Bâle, Liestal, Saint-Gall
- INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
NCT03838042Recrutement en coursPhase 1 · Phase 2
En Suisse : Zurich